Product Information

GLIPIZIDE-METFORMIN 2.5-500 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2131 per EA under NDC 00093745601. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Oct 28, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE-METFORMIN 2.5-500 MG

Glipizide and Metformin Hydrochloride
$0.2131per EA

Strength

2.5; 500 mg/1; mg/1

NDC

00093745601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077270

FDA Approved

10/28/2005

TE Code

AB

On Market Since

10/28/2005

Pharmacological Classes

Biguanide
Biguanides
Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 53.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2131 per EA
All-time high$0.6303 (Aug 10, 2016)
All-time low$0.1992 (Jun 23, 2021)
52-week high$0.3088
52-week low$0.2131
Median price$0.2977
Average price$0.3477
Largest weekly change+43.5% (Sep 23, 2020)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.4%

3M

-9.1%

6M

-8.3%

1Y

-28.8%

3Y

-28.4%

5Y

-1.4%

All

-53.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLIPIZIDE-METFORMIN 2.5-500 MG?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE-METFORMIN 2.5-500 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.2131 per EA (NDC 00093745601), effective Nov 11, 2026.

How has the price of GLIPIZIDE-METFORMIN 2.5-500 MG changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has declined 53.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE-METFORMIN 2.5-500 MG?

Since Nov 28, 2013, the NADAC for GLIPIZIDE-METFORMIN 2.5-500 MG has ranged from a low of $0.1992 (Jun 23, 2021) to a high of $0.6303 (Aug 10, 2016), with a median of $0.2977 per EA.

Are there cheaper alternatives to GLIPIZIDE-METFORMIN 2.5-500 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLIPIZIDE-METFORMIN 2.5-500 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures GLIPIZIDE-METFORMIN 2.5-500 MG?

GLIPIZIDE-METFORMIN 2.5-500 MG (NDC 00093745601) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.